Publications by authors named "Maria Tzefos"

Claim this Profile
E
Evaluating second-line treatment options for type 2 diabetes: focus on secondary effects of GLP-1 agonists and DPP-4 inhibitors.
Cassie L Boland, Michelle Degeeter, Donald S Nuzum, Maria Tzefos

Ann Pharmacother· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Clinical Efficacy and Safety of Glucagon-Like Peptide-1 (GLP-1) Agonists in Adults with Type 2 Diabetes Mellitus.
Kira R Brice, Maria K Tzefos

Clin Med Insights Endocrinol Diabetes· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy.
Maria Tzefos, Jacqueline L Olin

J Clin Lipidol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy and safety of once-weekly glucagon-like peptide-1 agonists in development for treatment of type 2 diabetes mellitus in adults.
Maria Tzefos, Kira Harris, Adriane Brackett

Ann Pharmacother· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon-like peptide-1 analog and insulin combination therapy in the management of adults with type 2 diabetes mellitus.
Maria Tzefos, Jacqueline L Olin

Ann Pharmacother· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fesoterodine for the treatment of overactive bladder.
Maria Tzefos, Christian Dolder, Jacqueline L Olin

Ann Pharmacother· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis